Oxford University’s clinical trials for a coronavirus vaccine have been suspended after a participant fell ill with an “unexplained illness”.
Author: Ipsita Sarkar
Ipsita (also known as Ippy) is the Science and Tech Editor at the Oxford Blue. A second year Medicine student at Trinity College, her hairstyle changes more frequently than the weather.
Oxford and Google research shows that tracing apps are effective at reducing COVID-19 impact
Research has found that the number of infections, deaths and hospitalisations caused by COVID-19 could be reduced through digital contact tracing systems, when used alongside other measures like social distancing and effective testing. A team of researchers from the University of Oxford’s Nuffield Department of Medicine and Google Research have used data from three counties Read More…
UK government launches £10 billion campaign to tackle obesity
Earlier this week, the Prime Minister, Boris Johnson, announced a series of measures to tackle obesity in both children and adults, in light of evidence that suggests it can make people more vulnerable to coronavirus. The campaign marks the beginnings of a change in focus with regards to healthcare, emphasising preventative measures and public health. Read More…
Trial data from Oxford vaccine shows great promise
Results from the Phase I/II trials for ChAdOx1 nCoV-19, the vaccine developed by scientists at The University of Oxford’s Jenner Institute and the Oxford Vaccine group, have been published today in scientific journal, The Lancet.
Oxford’s quest to find a vaccine against COVID-19 continues
Since April, a team of researchers at the Oxford Jenner Institute have been gradually coming closer to developing a highly sought-after vaccine for COVID-19, AZD1222 (formerly ChAdOx1), with Business Secretary Alok Sharma stating that “the UK continues to lead the global response to find a vaccine”.